Australia’s CSL has announced plans to expand its US presence over the next five years, resulting in approximately $1.5 billion in capital investments.

The US Food and Drug Administration today announced it has approved Danish biotech firm Genmab’s Epkinly (epcoritamab-bysp) with lenalidomide and rituximab for relapsed or refractory follicular ...

Spanish plasma-based medicines producer Grifols today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for THROMBATE III, the company’s antithrombin III ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major Eli Lilly for the development of therapeutics by utilizing ABL Bio’s Grabody ...

Swiss generics and biosimilars company Sandoz has announced the launch of Tyruko (natalizumab-sztn) in the USA.

India’s Zydus Lifesciences has received final approval from the US Food and Drug Administration (FDA) for diroximel fumarate delayed-release capsules, 231mg (Biogen’s Vumerity delayed-release capsules ...

A major British initiative is set to repurpose used nuclear materials, converting them into a consistent supply for innovative cancer treatments. The £9.9 million ($13 million) from the Innovate UK ...

Shares of US clinical-stage biopharmaceutical company Nuvalent jumped more than 15% to $111.22 by midday yesterday, after it announced positive top-line pivotal data for neladalkib.

South Korean biosimilars developer Celltrion today announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid formulation, the world’s first ...

Canadian firm Zymeworks, a biotech managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, has announced a new strategy.

US industry group PhRMA says three years of Inflation Reduction Act implementation have coincided with rising Medicare Part D premiums, fewer standalone plans and growing barriers to treatment. The ...

New government funding will help make the boldest ideas in UK life sciences a reality – from putting robots to work in factories making medicines, to turning spent nuclear fuel into the next ...